Sumitomo Mitsui DS Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.1M | Buy |
313,820
+16,753
| +6% | +$962K | 0.12% | 143 |
|
|
2026
Q1 | $18M | Sell |
297,067
-3,459
| -1% | -$202K | 0.15% | 133 |
|
|
2025
Q4 | $16.2M | Buy |
300,526
+4,269
| +1% | +$205K | 0.13% | 142 |
|
|
2025
Q3 | $13.4M | Buy |
296,257
+6,757
| +2% | +$316K | 0.11% | 165 |
|
|
2025
Q2 | $13.4M | Buy |
289,500
+18,398
| +7% | +$903K | 0.12% | 153 |
|
|
2025
Q1 | $16.5M | Buy |
271,102
+12,618
| +5% | +$735K | 0.17% | 118 |
|
|
2024
Q4 | $14.6M | Sell |
258,484
-2,904
| -1% | -$162K | 0.15% | 123 |
|
|
2024
Q3 | $13.5M | Buy |
261,388
+7,340
| +3% | +$344K | 0.15% | 130 |
|
|
2024
Q2 | $10.6M | Buy |
254,048
+587
| +0.2% | +$26.3K | 0.12% | 146 |
|
|
2024
Q1 | $13.7M | Buy |
253,461
+24,049
| +10% | +$1.23M | 0.17% | 107 |
|
|
2023
Q4 | $11.8M | Buy |
229,412
+109
| +0% | +$5.72K | 0.15% | 142 |
|
|
2023
Q3 | $13.3M | Buy |
229,303
+2,537
| +1% | +$155K | 0.21% | 91 |
|
|
2023
Q2 | $14.5M | Buy |
226,766
+44,213
| +24% | +$2.96M | 0.22% | 86 |
|
|
2023
Q1 | $12.7M | Buy |
182,553
+7,783
| +4% | +$549K | 0.23% | 84 |
|
|
2022
Q4 | $12.6M | Buy |
174,770
+8,136
| +5% | +$613K | 0.25% | 75 |
|
|
2022
Q3 | $11.8M | Buy |
166,634
+7,794
| +5% | +$565K | 0.27% | 71 |
|
|
2022
Q2 | $12.2M | Buy |
158,840
+12,439
| +8% | +$947K | 0.29% | 70 |
|
|
2022
Q1 | $10.7M | Sell |
146,401
-3,025
| -2% | -$203K | 0.23% | 88 |
|
|
2021
Q4 | $9.32M | Buy |
149,426
+4,882
| +3% | +$286K | 0.19% | 101 |
|
|
2021
Q3 | $8.55M | Sell |
144,544
-955
| -0.7% | -$62.9K | 0.2% | 103 |
|
|
2021
Q2 | $9.72M | Sell |
145,499
-1,251
| -0.9% | -$81.6K | 0.23% | 93 |
|
|
2021
Q1 | $9.26M | Buy |
146,750
+1,020
| +0.7% | +$63.5K | 0.24% | 92 |
|
|
2020
Q4 | $9.04M | Sell |
145,730
-2,636
| -2% | -$162K | 0.26% | 83 |
|
|
2020
Q3 | $8.94M | Buy |
148,366
+4,439
| +3% | +$267K | 0.28% | 79 |
|
|
2020
Q2 | $8.46M | Sell |
143,927
-2,921
| -2% | -$175K | 0.29% | 78 |
|
|
2020
Q1 | $8.19M | Sell |
146,848
-778
| -0.5% | -$47.6K | 0.34% | 67 |
|
|
2019
Q4 | $9.48M | Buy |
147,626
+45,831
| +45% | +$2.62M | 0.32% | 69 |
|
|
2019
Q3 | $5.16M | Buy |
101,795
+9,660
| +10% | +$454K | 0.19% | 111 |
|
|
2019
Q2 | $4.18M | Sell |
92,135
-22,803
| -20% | -$1.06M | 0.17% | 124 |
|
|
2019
Q1 | $5.48M | Buy |
114,938
+5,830
| +5% | +$290K | 0.09% | 183 |
|
|
2018
Q4 | $5.67M | Sell |
109,108
-5,106
| -4% | -$274K | 0.1% | 160 |
|
|
2018
Q3 | $7.09M | Sell |
114,214
-811
| -0.7% | -$48.1K | 0.11% | 154 |
|
|
2018
Q2 | $6.37M | Buy |
115,025
+1,068
| +0.9% | +$57.7K | 0.1% | 162 |
|
|
2018
Q1 | $7.21M | Sell |
113,957
-3,931
| -3% | -$253K | 0.11% | 152 |
|
|
2017
Q4 | $7.22M | Sell |
117,888
-7,862
| -6% | -$492K | 0.11% | 159 |
|
|
2017
Q3 | $8.02M | Sell |
125,750
-7,593
| -6% | -$443K | 0.13% | 153 |
|
|
2017
Q2 | $7.43M | Sell |
133,343
-5,274
| -4% | -$287K | 0.12% | 160 |
|
|
2017
Q1 | $7.54M | Sell |
138,617
-147,279
| -52% | -$8.08M | 0.13% | 162 |
|
|
2016
Q4 | $16.7M | Sell |
285,896
-8,166
| -3% | -$446K | 0.32% | 87 |
|
|
2016
Q3 | $15.9M | Buy |
294,062
+33,497
| +13% | +$2.15M | 0.35% | 94 |
|
|
2016
Q2 | $19.2M | Sell |
260,565
-62,791
| -19% | -$4.44M | 0.58% | 43 |
|
|
2016
Q1 | $20.7M | Buy |
323,356
+61,705
| +24% | +$3.89M | 0.64% | 38 |
|
|
2015
Q4 | $18M | Sell |
261,651
-53,543
| -17% | -$3.54M | 0.61% | 40 |
|
|
2015
Q3 | $18.7M | Buy |
315,194
+14,020
| +5% | +$889K | 0.64% | 34 |
|
|
2015
Q2 | $20M | Buy |
301,174
+279
| +0.1% | +$18.4K | 0.64% | 33 |
|
|
2015
Q1 | $19.4M | Sell |
300,895
-5,563
| -2% | -$348K | 0.59% | 40 |
|
|
2014
Q4 | $18.1M | Buy |
306,458
+48,231
| +19% | +$2.72M | 0.56% | 46 |
|
|
2014
Q3 | $13.2M | Buy |
258,227
+93,277
| +57% | +$4.66M | 0.41% | 70 |
|
|
2014
Q2 | $8M | Sell |
164,950
-9,761
| -6% | -$481K | 0.23% | 120 |
|
|
2014
Q1 | $9.08M | Sell |
174,711
-11,208
| -6% | -$596K | 0.27% | 97 |
|
|
2013
Q4 | $9.88M | Sell |
185,919
-14,449
| -7% | -$736K | 0.29% | 87 |
|
|
2013
Q3 | $9.27M | Sell |
200,368
-10,238
| -5% | -$449K | 0.27% | 87 |
|
|
2013
Q2 | $9.41M | Buy |
+210,606
| New | +$9.14M | 0.27% | 84 |
|
Other funds holding BMY
Sumitomo Mitsui DS Asset Management's BMY Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, buying an estimated $962K and bringing the position to 313,820 shares worth $18.1M. The position accounts for 0.12% of the portfolio, ranked #143.
Sumitomo Mitsui DS Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.7M in Q1 2016. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 313,820 shares of Bristol-Myers Squibb worth $18.1M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 16,753 Bristol-Myers Squibb shares in Q2 2026, an estimated $962K.
- Bristol-Myers Squibb made up 0.12% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #143 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Sumitomo Mitsui DS Asset Management's Bristol-Myers Squibb position peaked at $20.7M in Q1 2016.
- 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.